You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Porcupine inhibitor

Showing 26 - 50 of 7,356
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, PD-1 Inhibitor)

Recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • Denver, Colorado
  • +19 more
Jan 27, 2023

Health Care Interventions and Outcomes of Major Bleedings in

Not yet recruiting
  • Major Bleeding
  • None (Observational study)
  • (no location specified)
Nov 17, 2023

Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)

Recruiting
  • Tumor, Solid
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Nov 30, 2022

Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • B-Cell Lymphoproliferative Disorder
  • Boston, Massachusetts
  • +2 more
Feb 18, 2023

Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)

Recruiting
  • Toxic Epidermal Necrolysis
  • Fuzhou, Fujian, China
    Department of Dermatology, the First Affiliated Hospital of Fuji
Oct 31, 2023

Ovarian Cancer Recurrent Trial in Birmingham (M4344+Niraparib)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 5, 2023

Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in United States (VS-6766 and sotorasib)

Recruiting
  • Non Small Cell Lung Cancer
  • KRAS Activating Mutation
  • avutometinib (VS-6766) and sotorasib
  • Washington, District of Columbia
  • +6 more
Jan 31, 2023

Determine Pro-Inflammatory Cytokine Kinetics During Immune

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Melanoma
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jan 30, 2023

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930, Eculizumab, Ravulizumab)

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Paris, France
    • +6 more
    Dec 15, 2022

    NSCLC Trial in Worldwide (Tepotinib, Osimertinib)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Yuma, Arizona
    • +178 more
    Dec 19, 2022

    Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)

    Active, not recruiting
    • Depressive Disorder, Major
    • Ciudad Autonoma de Buenos Aires, Argentina
    • +58 more
    Jan 31, 2023

    Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)

    Active, not recruiting
    • Breast Cancer
    • Guangzhou, Guangdong, China
      State Key Laboratory of Oncology in South China, Sun Yat-sen Uni
    Jan 27, 2023

    Advanced Solid Tumor Trial in Beijing (Inosine 0.2g orally 3 times/day, PD-1/PD-L1 inhibitor ,chemo/targeting)

    Completed
    • Advanced Solid Tumor
    • Inosine 0.2g orally 3 times/day
    • PD-1/PD-L1 inhibitor ,chemotherapy/targeting
    • Beijing, Beijing, China
      Qin li
    Mar 30, 2023

    NSCLC Trial in Worldwide (JTX-4014, Vopratelimab)

    Active, not recruiting
    • NSCLC
    • Minsk, Belarus
    • +70 more
    Jan 18, 2023

    Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

    Recruiting
    • Ovarian Cancer
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Jul 13, 2022

      Non Small Cell Lung Cancer, Urothelial Cancer, Renal Cell Carcinoma Trial in Worldwide (INCB086550)

      Active, not recruiting
      • Non Small Cell Lung Cancer
      • +4 more
      • Burgas, Bulgaria
      • +19 more
      Oct 20, 2022

      Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)

      Not yet recruiting
      • Diffuse Glioma
      • Malignant Glioma
      • Biospecimen Collection
      • +6 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Feb 6, 2023

      Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

      Recruiting
      • Advanced Solid Tumor
      • Refractory Tumor
      • Radiotherapy
      • +4 more
      • Suzhou, China
        The Second Affiliated Hospital of SchoowUniversity
      Sep 14, 2023

      Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

      Recruiting
      • Migraine
      • +3 more
      • Click Digital Therapeutic
      • New York, New York
        Click Therapeutics
      Aug 15, 2023

      Advanced Lung Squamous Cell Carcinoma Trial in Chengdu (low-dose radiation therapy and stereotactic body radiation therapy,

      Not yet recruiting
      • Advanced Lung Squamous Cell Carcinoma
      • low-dose radiation therapy and stereotactic body radiation therapy
      • +2 more
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Nov 13, 2023

      Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +9 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Jan 25, 2023

      Stomach Tumors Trial in Seoul (Molecular profiling)

      Completed
      • Stomach Neoplasms
      • Molecular profiling
      • Seoul, Korea, Republic of
      • +1 more
      Jun 13, 2022

      Hypertension Trial in Burke (lorundrostat, Placebo)

      Recruiting
      • Hypertension
      • Burke, Virginia
        Burke Internal Medicine
      Aug 2, 2023

      Brain and CNS Tumors Trial in United States (BGB 324 (before surgery), BGB 324 (after surgery))

      Active, not recruiting
      • Brain and Central Nervous System Tumors
      • BGB 324 (before surgery)
      • BGB 324 (after surgery)
      • Birmingham, Alabama
      • +5 more
      Dec 1, 2022

      Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

      Not yet recruiting
      • Breast Cancer
      • +2 more
      • Boston, Massachusetts
      • +7 more
      Aug 14, 2023